Login
$MLP
$14.31 +$0.16 (1.13%) Close

Consolidated Balance Sheets (Current Period Unaudited)

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
CURRENT ASSETS
Cash and cash equivalents
Cash, restricted
Accounts receivable, net
Investments, current portion
Prepaid expenses and other assets
Assets held for sale
Total current assets
Land
Land improvements
Buildings
Machinery and equipment
Total Property & Equipment
Less accumulated depreciation
PROPERTY & EQUIPMENT, NET
OTHER ASSETS
Investments, noncurrent portion
Investment in joint venture
Deferred development costs
Development Project
Agave Venture
Total deferred development costs
Right of use assets
Other noncurrent assets
Total other assets
TOTAL ASSETS
Liabilities, Current
Accounts payable
Payroll and employee benefits
Accrued retirement benefits, current portion
Deferred revenue, current portion
Long-term debt, current portion
Line of credit
Lease liability, current portion
Other current liabilities
Contract overbillings
Total current liabilities
Liabilities, Noncurrent
Accrued retirement benefits, noncurrent portion
Line of credit
Deferred revenue, noncurrent portion
License
Excluding Deposits
Member Deposits
Long-term debt, noncurrent portion
Other noncurrent liabilities
Lease liability, noncurrent portion
Total long-term liabilities
TOTAL LIABILITIES
STOCKHOLDERS' EQUITY
Preferred stock--$0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding
Common stock--$0.0001 par value; 43,000,000 shares authorized; 19,876,696 and 19,755,431 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Additional paid-in-capital
Accumulated deficit
Accumulated other comprehensive loss
Total stockholders' equity
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support